What is Thermo Fishr Sci's earnings per share (EPS)?

Thermo Fishr Sci (TMO) reported diluted earnings per share of $17.74 for fiscal year 2025. This represents a 7.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Thermo Fishr Sci Financials

TMO

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Thermo Fishr Sci (TMO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 53/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Thermo Fishr Sci has an operating margin of 17.4%, meaning the company retains $17 of operating profit per $100 of revenue. This results in a moderate score of 61/100, indicating healthy but not exceptional operating efficiency. This is up from 17.1% the prior year.

Growth

Thermo Fishr Sci's revenue grew a modest 3.9% year-over-year to $44.6B. This slow but positive growth earns a score of 40/100.

Leverage

Thermo Fishr Sci carries a low D/E ratio of 0.73, meaning only $0.73 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 87/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Thermo Fishr Sci's current ratio of 1.89 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Thermo Fishr Sci has a free cash flow margin of 14.1%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Thermo Fishr Sci's ROE of 12.6% shows moderate profitability relative to equity, earning a score of 39/100. This is down from 12.8% the prior year.

Altman Z-Score Safe

3.49

Thermo Fishr Sci scores 3.49, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($186.0B) relative to total liabilities ($56.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

Thermo Fishr Sci passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.17x

For every $1 of reported earnings, Thermo Fishr Sci generates $1.17 in operating cash flow ($7.8B OCF vs $6.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

5.5x

Thermo Fishr Sci earns $5.5 in operating income for every $1 of interest expense ($7.7B vs $1.4B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$44.6B

YoY+3.9%

5Y CAGR+6.7%

10Y CAGR+10.1%

Thermo Fishr Sci generated $44.6B in revenue in fiscal year 2025. This represents an increase of 3.9% from the prior year.

EBITDA

$10.5B

YoY+0.8%

5Y CAGR+0.8%

10Y CAGR+10.1%

Thermo Fishr Sci's EBITDA was $10.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.8% from the prior year.

Net Income

$6.7B

YoY+5.8%

5Y CAGR+1.0%

10Y CAGR+13.0%

Thermo Fishr Sci reported $6.7B in net income in fiscal year 2025. This represents an increase of 5.8% from the prior year.

EPS (Diluted)

$17.74

YoY+7.3%

5Y CAGR+2.1%

10Y CAGR+13.7%

Thermo Fishr Sci earned $17.74 per diluted share (EPS) in fiscal year 2025. This represents an increase of 7.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$6.3B

YoY-13.4%

5Y CAGR-1.6%

10Y CAGR+9.6%

Thermo Fishr Sci generated $6.3B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 13.4% from the prior year.

Cash & Debt

$9.9B

YoY+145.7%

5Y CAGR-0.9%

10Y CAGR+36.1%

Thermo Fishr Sci held $9.9B in cash against $39.2B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.72

YoY+10.3%

5Y CAGR+14.3%

10Y CAGR+11.1%

Thermo Fishr Sci paid $1.72 per share in dividends in fiscal year 2025. This represents an increase of 10.3% from the prior year.

Shares Outstanding

371M

YoY-1.5%

5Y CAGR-1.2%

10Y CAGR-0.6%

Thermo Fishr Sci had 371M shares outstanding in fiscal year 2025. This represents a decrease of 1.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

17.4%

YoY+0.3pp

5Y CAGR-6.8pp

10Y CAGR+3.6pp

Thermo Fishr Sci's operating margin was 17.4% in fiscal year 2025, reflecting core business profitability. This is up 0.3 percentage points from the prior year.

Net Margin

15.0%

YoY+0.3pp

5Y CAGR-4.7pp

10Y CAGR+3.4pp

Thermo Fishr Sci's net profit margin was 15.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.3 percentage points from the prior year.

Return on Equity

12.6%

YoY-0.2pp

5Y CAGR-5.9pp

10Y CAGR+3.3pp

Thermo Fishr Sci's ROE was 12.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$1.4B

YoY+0.5%

5Y CAGR+3.4%

10Y CAGR+7.3%

Thermo Fishr Sci invested $1.4B in research and development in fiscal year 2025. This represents an increase of 0.5% from the prior year.

Share Buybacks

$3.0B

YoY-25.0%

5Y CAGR+14.9%

10Y CAGR+19.6%

Thermo Fishr Sci spent $3.0B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 25.0% from the prior year.

Capital Expenditures

$1.5B

YoY+8.9%

5Y CAGR+0.7%

10Y CAGR+13.7%

Thermo Fishr Sci invested $1.5B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 8.9% from the prior year.

TMO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$44.6B+3.9%	$42.9B+0.1%	$42.9B-4.6%	$44.9B+14.5%	$39.2B+21.7%	$32.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$1.4B+0.5%	$1.4B+4.0%	$1.3B-9.1%	$1.5B+4.6%	$1.4B+19.1%	$1.2B
SG&A Expenses	$8.7B+1.6%	$8.6B+1.8%	$8.4B-6.1%	$9.0B+12.3%	$8.0B+15.5%	$6.9B
Operating Income	$7.7B+5.6%	$7.3B+7.0%	$6.9B-18.3%	$8.4B-16.3%	$10.0B+28.7%	$7.8B
Interest Expense	$1.4B+2.1%	$1.4B+1.1%	$1.4B+89.4%	$726.0M+35.4%	$536.0M-3.1%	$553.0M
Income Tax	$547.0M-16.7%	$657.0M+131.3%	$284.0M-59.6%	$703.0M-36.6%	$1.1B+30.5%	$850.0M
Net Income	$6.7B+5.8%	$6.3B+5.7%	$6.0B-13.9%	$7.0B-9.9%	$7.7B+21.2%	$6.4B
EPS (Diluted)	$17.74+7.3%	$16.53+7.0%	$15.45-12.4%	$17.63-9.4%	$19.46+21.9%	$15.96

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$12.2B+9.8%	$11.1B+2.5%	$10.9B+4.7%	$10.4B-9.0%	$11.4B+7.5%	$10.6B+0.5%	$10.5B+1.9%	$10.3B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$357.0M+3.2%	$346.0M-1.7%	$352.0M+2.9%	$342.0M-8.6%	$374.0M+8.1%	$346.0M+2.1%	$339.0M+2.4%	$331.0M
SG&A Expenses	$2.4B+8.8%	$2.2B+1.0%	$2.1B+3.0%	$2.1B-5.7%	$2.2B+5.0%	$2.1B-0.6%	$2.1B-3.3%	$2.2B
Operating Income	$2.3B+16.2%	$1.9B+5.8%	$1.8B+6.9%	$1.7B-14.9%	$2.0B+9.7%	$1.8B+1.0%	$1.8B+9.4%	$1.7B
Interest Expense	$365.0M+5.2%	$347.0M-14.1%	$404.0M+33.3%	$303.0M-4.4%	$317.0M-11.0%	$356.0M+0.6%	$354.0M-2.5%	$363.0M
Income Tax	$153.0M-26.1%	$207.0M+125.0%	$92.0M-3.2%	$95.0M-36.2%	$149.0M+50.5%	$99.0M-22.7%	$128.0M-54.4%	$281.0M
Net Income	$2.0B+21.3%	$1.6B-0.1%	$1.6B+7.0%	$1.5B-17.3%	$1.8B+12.0%	$1.6B+5.3%	$1.5B+16.3%	$1.3B
EPS (Diluted)	N/A	$4.27-0.2%	$4.28+7.5%	$3.98	N/A	$4.25+5.2%	$4.04+16.8%	$3.46

TMO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$110.3B+13.4%	$97.3B-1.4%	$98.7B+1.6%	$97.2B+2.1%	$95.1B+37.8%	$69.1B
Current Assets	$28.7B+29.7%	$22.1B-10.0%	$24.6B-2.5%	$25.2B+25.4%	$20.1B-8.4%	$22.0B
Cash & Equivalents	$9.9B+145.7%	$4.0B-50.4%	$8.1B-5.2%	$8.5B+90.4%	$4.5B-56.6%	$10.3B
Inventory	$5.4B+9.0%	$5.0B-2.2%	$5.1B-9.7%	$5.6B+11.5%	$5.1B+25.4%	$4.0B
Accounts Receivable	$8.9B+8.7%	$8.2B-0.4%	$8.2B+1.3%	$8.1B+1.7%	$8.0B+38.9%	$5.7B
Goodwill	$49.4B+7.7%	$45.9B+4.2%	$44.0B+6.9%	$41.2B-1.7%	$41.9B+61.0%	$26.0B
Total Liabilities	$56.9B+19.3%	$47.7B-8.2%	$52.0B-2.2%	$53.2B-2.1%	$54.3B+57.3%	$34.5B
Current Liabilities	$15.2B+13.9%	$13.3B-4.9%	$14.0B-17.6%	$17.0B+26.6%	$13.4B+30.4%	$10.3B
Long-Term Debt	$39.2B+26.1%	$31.1B-10.5%	$34.7B+1.3%	$34.3B-1.1%	$34.7B+81.5%	$19.1B
Total Equity	$53.4B+7.7%	$49.6B+6.1%	$46.7B+6.3%	$44.0B+7.8%	$40.8B+18.2%	$34.5B
Retained Earnings	$59.2B+11.4%	$53.1B+12.1%	$47.4B+13.0%	$41.9B+18.3%	$35.4B+26.0%	$28.1B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$110.3B+7.1%	$103.0B+1.8%	$101.2B+2.2%	$99.0B+1.8%	$97.3B-3.0%	$100.4B+1.9%	$98.5B+1.4%	$97.1B
Current Assets	$28.7B+28.8%	$22.3B-9.3%	$24.6B+5.2%	$23.4B+5.6%	$22.1B-6.9%	$23.8B-6.6%	$25.5B+7.8%	$23.6B
Cash & Equivalents	$9.9B+397.1%	$2.0B-56.7%	$4.6B+10.7%	$4.1B+3.1%	$4.0B-13.7%	$4.6B-34.3%	$7.1B+28.6%	$5.5B
Inventory	$5.4B-5.6%	$5.7B+3.3%	$5.6B+6.4%	$5.2B+4.9%	$5.0B-8.3%	$5.4B+4.5%	$5.2B+1.3%	$5.1B
Accounts Receivable	$8.9B-0.1%	$8.9B+3.7%	$8.6B+1.6%	$8.5B+3.2%	$8.2B-0.8%	$8.3B+3.9%	$7.9B+0.2%	$7.9B
Goodwill	$49.4B+0.2%	$49.3B+4.3%	$47.2B+1.6%	$46.5B+1.4%	$45.9B-1.9%	$46.7B+6.6%	$43.8B0.0%	$43.8B
Total Liabilities	$56.9B+9.5%	$52.0B+2.5%	$50.7B+2.1%	$49.7B+4.0%	$47.7B-7.1%	$51.4B+0.6%	$51.1B-1.0%	$51.6B
Current Liabilities	$15.2B+2.0%	$14.9B+17.1%	$12.7B-3.5%	$13.2B-1.2%	$13.3B-8.7%	$14.6B-1.2%	$14.8B+6.0%	$13.9B
Long-Term Debt	$39.2B+10.4%	$35.5B+1.3%	$35.0B+3.1%	$34.0B+9.4%	$31.1B-11.5%	$35.1B-0.2%	$35.2B-0.6%	$35.4B
Total Equity	$53.4B+4.7%	$51.0B+1.0%	$50.5B+2.3%	$49.4B-0.4%	$49.6B+1.2%	$49.0B+3.3%	$47.4B+4.2%	$45.5B
Retained Earnings	$59.2B+3.1%	$57.4B+2.6%	$55.9B+2.7%	$54.4B+2.5%	$53.1B+3.3%	$51.4B+3.0%	$49.9B+2.9%	$48.5B

TMO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$7.8B-9.8%	$8.7B+3.1%	$8.4B-8.2%	$9.2B-1.7%	$9.3B+12.3%	$8.3B
Capital Expenditures	$1.5B+8.9%	$1.4B-5.3%	$1.5B-34.1%	$2.2B-11.1%	$2.5B+71.2%	$1.5B
Free Cash Flow	$6.3B-13.4%	$7.3B+4.9%	$6.9B+0.2%	$6.9B+1.8%	$6.8B-0.4%	$6.8B
Investing Cash Flow	-$4.0B+30.7%	-$5.8B-13.6%	-$5.1B-138.2%	-$2.2B+90.2%	-$21.9B-1352.5%	-$1.5B
Financing Cash Flow	$1.8B+126.5%	-$6.8B-87.5%	-$3.6B-28.9%	-$2.8B-142.7%	$6.6B+586.2%	$959.0M
Dividends Paid	$636.0M+9.1%	$583.0M+11.5%	$523.0M+14.9%	$455.0M+15.2%	$395.0M+17.2%	$337.0M
Share Buybacks	$3.0B-25.0%	$4.0B+33.3%	$3.0B0.0%	$3.0B+50.0%	$2.0B+33.3%	$1.5B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$3.5B+54.4%	$2.2B+60.0%	$1.4B+93.5%	$723.0M-78.0%	$3.3B+51.9%	$2.2B+10.5%	$2.0B+56.7%	$1.3B
Capital Expenditures	$465.0M+15.1%	$404.0M+37.4%	$294.0M-18.8%	$362.0M-24.6%	$480.0M+76.5%	$272.0M-9.6%	$301.0M-13.3%	$347.0M
Free Cash Flow	$3.0B+63.1%	$1.8B+66.1%	$1.1B+206.1%	$361.0M-87.2%	$2.8B+48.4%	$1.9B+14.2%	$1.7B+83.5%	$904.0M
Investing Cash Flow	$891.0M+121.6%	-$4.1B-1331.6%	-$288.0M+45.4%	-$527.0M-2735.0%	$20.0M+100.6%	-$3.6B-1314.2%	-$253.0M+87.5%	-$2.0B
Financing Cash Flow	$3.5B+657.9%	-$632.0M+36.2%	-$991.0M-871.6%	-$102.0M+97.2%	-$3.7B-208.1%	-$1.2B-934.8%	-$115.0M+93.7%	-$1.8B
Dividends Paid	$162.0M-0.6%	$163.0M+0.6%	$162.0M+8.7%	$149.0M0.0%	$149.0M-0.7%	$150.0M+0.7%	$149.0M+10.4%	$135.0M
Share Buybacks	$37.0M-96.2%	$963.0M	$0-100.0%	$2.0B+100.0%	$1.0B	$0	$0-100.0%	$3.0B

TMO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	17.4%+0.3pp	17.1%+1.1pp	16.0%-2.7pp	18.7%-6.9pp	25.6%+1.4pp	24.2%
Net Margin	15.0%+0.3pp	14.8%+0.8pp	14.0%-1.5pp	15.5%-4.2pp	19.7%-0.1pp	19.8%
Return on Equity	12.6%-0.2pp	12.8%-0.1pp	12.8%-3.0pp	15.8%-3.1pp	18.9%+0.5pp	18.5%
Return on Assets	6.1%-0.4pp	6.5%+0.4pp	6.1%-1.1pp	7.2%-1.0pp	8.1%-1.1pp	9.2%
Current Ratio	1.89+0.2	1.66-0.1	1.75+0.3	1.48-0.0	1.50-0.6	2.13
Debt-to-Equity	0.73+0.1	0.63-0.1	0.74-0.0	0.78-0.1	0.85+0.3	0.55
FCF Margin	14.1%-2.8pp	17.0%+0.8pp	16.2%+0.8pp	15.4%-1.9pp	17.3%-3.8pp	21.1%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	18.5%+1.0pp	17.4%+0.5pp	16.9%+0.3pp	16.6%-1.1pp	17.7%+0.4pp	17.3%+0.1pp	17.3%+1.2pp	16.1%
Net Margin	16.1%+1.5pp	14.5%-0.4pp	14.9%+0.3pp	14.6%-1.4pp	16.0%+0.6pp	15.4%+0.7pp	14.7%+1.8pp	12.9%
Return on Equity	3.7%+0.5pp	3.2%-0.0pp	3.2%+0.1pp	3.1%-0.6pp	3.7%+0.3pp	3.3%+0.1pp	3.3%+0.3pp	2.9%
Return on Assets	1.8%+0.2pp	1.6%-0.0pp	1.6%+0.1pp	1.5%-0.4pp	1.9%+0.3pp	1.6%+0.1pp	1.6%+0.2pp	1.4%
Current Ratio	1.89+0.4	1.50-0.4	1.93+0.2	1.77+0.1	1.66+0.0	1.63-0.1	1.72+0.0	1.70
Debt-to-Equity	0.73+0.0	0.700.0	0.690.0	0.69+0.1	0.63-0.1	0.72-0.0	0.74-0.0	0.78
FCF Margin	24.5%+8.0pp	16.5%+6.3pp	10.2%+6.7pp	3.5%-21.2pp	24.7%+6.8pp	17.9%+2.1pp	15.7%+7.0pp	8.7%

Similar Companies

Danaher Corporation DHR

$136.6B

IDEXX Laboratories IDXX

$46.4B

Agilent Technologies Inc A

$32.6B

Mettler-Toledo MTD

$27.0B

PERKINELMER INC PKI

$14.5B

Frequently Asked Questions

What is Thermo Fishr Sci's annual revenue?

Thermo Fishr Sci (TMO) reported $44.6B in total revenue for fiscal year 2025. This represents a 3.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Thermo Fishr Sci's revenue growing?

Thermo Fishr Sci (TMO) revenue grew by 3.9% year-over-year, from $42.9B to $44.6B in fiscal year 2025.

Is Thermo Fishr Sci profitable?

Yes, Thermo Fishr Sci (TMO) reported a net income of $6.7B in fiscal year 2025, with a net profit margin of 15.0%.

What is Thermo Fishr Sci's EBITDA?

Thermo Fishr Sci (TMO) had EBITDA of $10.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Thermo Fishr Sci have?

As of fiscal year 2025, Thermo Fishr Sci (TMO) had $9.9B in cash and equivalents against $39.2B in long-term debt.

What is Thermo Fishr Sci's operating margin?

Thermo Fishr Sci (TMO) had an operating margin of 17.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Thermo Fishr Sci's net profit margin?

Thermo Fishr Sci (TMO) had a net profit margin of 15.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Thermo Fishr Sci pay dividends?

Yes, Thermo Fishr Sci (TMO) paid $1.72 per share in dividends during fiscal year 2025.

What is Thermo Fishr Sci's return on equity (ROE)?

Thermo Fishr Sci (TMO) has a return on equity of 12.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Thermo Fishr Sci's free cash flow?

Thermo Fishr Sci (TMO) generated $6.3B in free cash flow during fiscal year 2025. This represents a -13.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Thermo Fishr Sci's operating cash flow?

Thermo Fishr Sci (TMO) generated $7.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Thermo Fishr Sci's total assets?

Thermo Fishr Sci (TMO) had $110.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Thermo Fishr Sci's capital expenditures?

Thermo Fishr Sci (TMO) invested $1.5B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Thermo Fishr Sci spend on research and development?

Thermo Fishr Sci (TMO) invested $1.4B in research and development during fiscal year 2025.

Does Thermo Fishr Sci buy back shares?

Yes, Thermo Fishr Sci (TMO) spent $3.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Thermo Fishr Sci have outstanding?

Thermo Fishr Sci (TMO) had 371M shares outstanding as of fiscal year 2025.

What is Thermo Fishr Sci's current ratio?

Thermo Fishr Sci (TMO) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.

What is Thermo Fishr Sci's debt-to-equity ratio?

Thermo Fishr Sci (TMO) had a debt-to-equity ratio of 0.73 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Thermo Fishr Sci's return on assets (ROA)?

Thermo Fishr Sci (TMO) had a return on assets of 6.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Thermo Fishr Sci's Altman Z-Score?

Thermo Fishr Sci (TMO) has an Altman Z-Score of 3.49, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Thermo Fishr Sci's Piotroski F-Score?

Thermo Fishr Sci (TMO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Thermo Fishr Sci's earnings high quality?

Thermo Fishr Sci (TMO) has an earnings quality ratio of 1.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Thermo Fishr Sci cover its interest payments?

Thermo Fishr Sci (TMO) has an interest coverage ratio of 5.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Thermo Fishr Sci?

Thermo Fishr Sci (TMO) scores 53 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.